{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:18:05Z","timestamp":1766269085888,"version":"build-2065373602"},"reference-count":10,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.31744\/einstein_journal\/2025rc1534","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:51:16Z","timestamp":1761310276000},"source":"Crossref","is-referenced-by-count":1,"title":["Nitazoxanide and nonsteroidal anti-inflammatory drugs (NSAIDs): unveiling the connection in immediate hypersensitivity cross-reactions"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6440-1267","authenticated-orcid":false,"given":"Andr\u00e9 Luiz Oliveira","family":"Feodrippe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9882-5200","authenticated-orcid":false,"given":"Marcelo Vivolo","family":"Aun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7281-8432","authenticated-orcid":false,"given":"Elaine","family":"Gagete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8415-4274","authenticated-orcid":false,"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-7580","authenticated-orcid":false,"given":"Pedro","family":"Giavina-Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"10393","key":"key20251024125110_B1","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(23)00458-0","article-title":"Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes","volume":"401","author":"Wolf","year":"2023","unstructured":"Wolf J, Johnston RB, Ambelu A, Arnold BF, Bain R, Brauer M, et al. Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes. Lancet. 2023;401(10393):2060-71.","journal-title":"Lancet"},{"key":"key20251024125110_B2","first-page":"28216","article-title":"New derivative of 2-benzamido-5-nitrothiazoles","volume":"83","author":"Rossignol","year":"1975","unstructured":"Rossignol JF, Cavier R. New derivative of 2-benzamido-5-nitrothiazoles. Chem Abstr. 1975;83:28216.","journal-title":"Chem Abstr"},{"issue":"2","key":"key20251024125110_B3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0011-393X(98)85006-6","article-title":"Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt","volume":"59","author":"Abaza","year":"1998","unstructured":"Abaza H, El-Zayadi AR, Kabil SM, Rizk H. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt. Curr Ther Res. 1998;59(2):116-21.","journal-title":"Curr Ther Res"},{"key":"key20251024125110_B4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","unstructured":"Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res. 2014;110:94-103. Review.","journal-title":"Antiviral Res"},{"issue":"3","key":"key20251024125110_B5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","unstructured":"Rossignol JF. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. J Infect Public Health. 2016;9(3):227-30. Review.","journal-title":"J Infect Public Health"},{"issue":"4","key":"key20251024125110_B6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/med.21940","article-title":"Therapeutic potential of salicylamide derivatives for combating viral infections","volume":"43","author":"Xu","year":"2023","unstructured":"Xu J, Xue Y, Bolinger AA, Li J, Zhou M, Chen H, et al. Therapeutic potential of salicylamide derivatives for combating viral infections. Med Res Rev. 2023;43(4):897-931. Review.","journal-title":"Med Res Rev"},{"issue":"8","key":"key20251024125110_B7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5414\/CPP38387","article-title":"Nitazoxanide: pharmacokinetics and metabolism in man","volume":"38","author":"Broekhuysen","year":"2000","unstructured":"Broekhuysen J, Stockis A, Lins RL, De Graeve J, Rossignol JF. Nitazoxanide: pharmacokinetics and metabolism in man. Int J Clin Pharmacol Ther. 2000;38(8):387-94.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"key20251024125110_B8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/ACI.0000000000000411","article-title":"Drug-induced anaphylaxis: is it an epidemic?","volume":"18","author":"Giavina-Bianchi","year":"2018","unstructured":"Giavina-Bianchi P, Aun MV, Kalil J. Drug-induced anaphylaxis: is it an epidemic? Curr Opin Allergy Clin Immunol. 2018;18(1):59-65. Review.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"key20251024125110_B9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","unstructured":"Aun MV, Blanca M, Garro LS, Ribeiro MR, Kalil J, Motta AA, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414-20.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"key20251024125110_B10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/ACI.0000000000000292","article-title":"Angioedema associated with nonsteroidal anti-inflammatory drugs","volume":"16","author":"Giavina-Bianchi","year":"2016","unstructured":"Giavina-Bianchi P, Aun MV, Jares EJ, Kalil J. Angioedema associated with nonsteroidal anti-inflammatory drugs. Curr Opin Allergy Clin Immunol. 2016;16(4):323-32. Review.","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:51:18Z","timestamp":1761310278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/nitazoxanide-and-nonsteroidal-anti-inflammatory-drugs-nsaids-unveiling-the-connection-in-immediate-hypersensitivity-cross-reactions\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":10,"alternative-id":["10.31744\/einstein_journal\/2025RC1534"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025rc1534","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eRC1534"}}